Exact Mass: 290.2279

Exact Mass Matches: 290.2279

Found 176 metabolites which its exact mass value is equals to given mass value 290.2279, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Androsterone

(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H30O2 (290.2246)


Androsterone is an inactive breakdown metabolite of testosterone, the product of a reaction mediated by the enzyme oxidative 17beta-hydroxysteroid dehydrogenase (EC 1.1.1.51, 17beta-HSD). Androsterone can also be metabolized from other adrenal androgens such as dehydroepiandrosterone, dihydrotestosterone, or androstenedione, and is considered an inactive end product. However, it can be a physiological effector in its own right. Androsterone might be converted back to dihydrotestosterone. Humans (and other primates) are unique among mammals in having high levels of circulating androsterone glucuronide, a process that is the major role of uridine-diphospho-glucuronosyltransferase enzymes (EC 2.4.1.17, UGT) for glucuronidation of steroid metabolism in humans. Conjugation of androsterone is a pathway found in all vertebrates and it is widely recognized that the liver is a major site of glucuronidation. However, it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide found in the human prostate, breast cyst fluid, and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues as well. In doping control, the ratio of androsterone/etiocholanolone provides valuable information that allows the assignment of a urine specimen to a particular person or the identification of urine samples with identical steroid profiles; this is particularly important to detect attempts of urine manipulation including urine alteration and substitution (PMID: 9188497, 17017935, 14643063, 12943709, 9699884, 17260133). Androsterone is an inactive breakdown metabolite of testosterone, the product of a reaction mediated by the enzyme oxidative 17beta-hydroxysteroid dehydrogenase (EC 1.1.1.51, 17beta-HSD). Androsterone is also can be metabolized from other adrenal androgens such as dehydroepiandrosterone, dihydrotestosterone or androstenedione, and is considered an inactive end product; however, it can be a physiological effector in its own right. Androsterone might be converted back to dihydrotestosterone. Humans (and other primates) are unique among mammals in having high levels of circulating androsterone glucuronide, a process that is the major role uridine-diphospho-glucuronosyltransferase (EC 2.4.1.17, UGT) enzymes for glucuronidation of steroid metabolism in humans. Conjugation of androsterone is a pathway found in all vertebrates and is widely recognized that the liver is a major site of glucuronidation; however it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide found in the human prostate, breast cyst fluid and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues as well. In doping control, the ratio of androsterone/etiocholanone provides valuable information that allows the assignment of a urine specimen to a particular person or the identification of urine samples with identical steroid profiles; this is particularly important to detect attempts of urine manipulation including urine alteration and substitution. (PMID: 9188497, 17017935, 14643063, 12943709, 9699884, 17260133) [HMDB] C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones CONFIDENCE standard compound; INTERNAL_ID 2804 CONFIDENCE standard compound; INTERNAL_ID 4166

   

succinylcholine

succinylcholine

C14H30N2O4+2 (290.2205)


M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents > M03AB - Choline derivatives D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

Dihydrotestosterone

(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one

C19H30O2 (290.2246)


Dihydrotestosterone is a potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. -- Pubchem; Dihydrotestosterone (DHT) (INN: androstanolone) is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, and adrenal glands by the enzyme 5-alpha-reductase by means of reducing the alpha 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. DHT is thought to be approximately 30 times more potent than testosterone because of increased affinity to the androgen receptor. A potent androgenic metabolite of testosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid. -- Pubchem; Dihydrotestosterone (DHT) (INN: androstanolone) is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, and adrenal glands by the enzyme 5-alpha-reductase by means of reducing the alpha 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. DHT is thought to be approximately 30 times more potent than testosterone because of increased affinity to the androgen receptor. -- Wikipedia [HMDB] G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BB - 5-androstanon (3) derivatives A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

16-Oxosteroid

16-Oxosteroid

C19H30O2 (290.2246)


   

Androst-5-ene-3beta,17beta-diol

(1S,2R,5S,10R,11S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-ene-5,14-diol

C19H30O2 (290.2246)


5-Androstenediol is a direct metabolite of the most abundant steroid produced by the human adrenal cortex, dehydroepiandrosterone (DHEA). 5-Androstenediol is less androgenic than 4-androstenediol, and stimulates the immune system. When administered to rats in vivo, 5-androstenediol has approximately 1/70 the androgenicity of DHEA, 1/185 the androgenicity of androstenedione, and 1/475 the androgenicity of testosterone (Wikipedia). Because it induces production of white blood cells and platelets, 5-androstenediol is being developed as a radiation countermeasure as Neumune (HE2100). An intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. 5-Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-fydroxysteroid dehydrogenase). Androstenediol is a term used to refer to two different steroids with molecular weights of 290.44: 4-androstenediol (4-androstene-3beta,17beta-diol) and 5-androstenediol (5-androstene-3beta,17beta-diol). 4-Androstenediol is closer to testosterone structurally, and has androgenic effects. 5-Androstenediol is a direct metabolite of the most abundant steroid produced by the human adrenal cortex, dehydroepiandrosterone (DHEA). 5-Androstenediol is less androgenic than 4-androstenediol, and stimulates the immune system. When administered to rats in vivo, 5-androstenediol has approximately 1/70 the androgenicity of DHEA, 1/185 the androgenicity of androstenedione, and 1/475 the androgenicity of testosterone (Coffey, 1988). Because it induces production of white blood cells and platelets, 5-androstenediol is being developed as a radiation countermeasure as Neumune(HE2100). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

Cetadiol

3beta,16alpha-Dihydroxy-5-androstene

C19H30O2 (290.2246)


   

11beta-Hydroxy-5alpha-androstan-17-one

11beta-Hydroxy-5alpha-androstan-17-one

C19H30O2 (290.2246)


   

17beta-Hydroxy-2alpha-methyl-5alpha-estran-3-one

(2alpha,5alpha,17beta)-17-Hydroxy-2-methylestran-3-one

C19H30O2 (290.2246)


   

Epiandrosterone

(1S,2S,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H30O2 (290.2246)


Epiandrosterone is a naturally occurring steroid synthesized in the adrenal cortex, gonads, brain, and gastrointestinal tract. It is less active than androsterone and excreted in small amounts in normal human urine. Epiandrosterone is a metabolite of the most abundant adrenal androgenic steroid dehydroepiandrosterone (DHEA) in young adult humans, but is not completely inactive and is considered an effector as well. Epiandrosterone is a precursor or substrate for cytochrome P450 species and enzymes (EC 1.14.13.100, 25-hydroxycholesterol 7alpha-hydroxylase) that produce 7alpha- and 7beta-hydroxylated metabolites in the human brain and other organs. These 7-hydroxylated derivatives exert anti-glucocorticoid and neuroprotective effects. (PMID: 17017935, 12475725, 15650074, 15784286) [HMDB] Epiandrosterone is a naturally occurring steroid synthesized in the adrenal cortex, gonads, brain, and gastrointestinal tract. It is less active than androsterone and excreted in small amounts in normal human urine. Epiandrosterone is a metabolite of the most abundant adrenal androgenic steroid dehydroepiandrosterone (DHEA) in young adult humans, but is not completely inactive and is considered an effector as well. Epiandrosterone is a precursor or substrate for cytochrome P450 species and enzymes (EC 1.14.13.100, 25-hydroxycholesterol 7alpha-hydroxylase) that produce 7alpha- and 7beta-hydroxylated metabolites in the human brain and other organs. These 7-hydroxylated derivatives exert anti-glucocorticoid and neuroprotective effects (PMID: 17017935, 12475725, 15650074, 15784286). C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones CONFIDENCE standard compound; INTERNAL_ID 4168 CONFIDENCE standard compound; INTERNAL_ID 2818 Epiandrosterone is a steroid hormone with weak androgenic activity. Epiandrosterone is naturally produced by the enzyme 5α-reductase from the adrenal hormone DHEA.

   

Etiocholanolone

(1S,2S,5R,7R,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H30O2 (290.2246)


Etiocholanolone is the 5-beta-reduced isomer of androsterone. Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine and is androgenically inactive. Classified a ketosteroid, it causes fever (it is a pyrogen), immunostimulation and leukocytosis. The pyrogenic effect of Etiocholanolone has been shown to be due to the release of interleukin-1 (IL-1) from the leukocytes that are mobilized in response to its production or injection. Etiocholanolone has anticonvulsant activity and may be an endogenous modulator of seizure susceptibility. Significantly increased values of etiocholanolone (along with testoterone and androsterone) an be detected in the urine of men with androgenic alopecia (male pattern baldness). [HMDB] Etiocholanolone is the 5-beta-reduced isomer of androsterone. Etiocholanolone is a major metabolite of testosterone and androstenedione in many mammalian species including humans. It is excreted in the urine and is androgenically inactive. Classified a ketosteroid, it causes fever (it is a pyrogen), immunostimulation and leukocytosis. The pyrogenic effect of Etiocholanolone has been shown to be due to the release of interleukin-1 (IL-1) from the leukocytes that are mobilized in response to its production or injection. Etiocholanolone has anticonvulsant activity and may be an endogenous modulator of seizure susceptibility. Significantly increased values of etiocholanolone (along with testoterone and androsterone) an be detected in the urine of men with androgenic alopecia (male pattern baldness). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C308 - Immunotherapeutic Agent > C2139 - Immunostimulant COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Etiocholanolone (5β-Androsterone) is the excreted metabolite of testosterone and has anticonvulsant activity[1]. Etiocholanolone is a less potent?neurosteroid positive allosteric modulator?(PAM) of the GABAA?receptor than its?enantiomer form[2]. Etiocholanolone (5β-Androsterone) is the excreted metabolite of testosterone and has anticonvulsant activity[1]. Etiocholanolone is a less potent?neurosteroid positive allosteric modulator?(PAM) of the GABAA?receptor than its?enantiomer form[2]. Etiocholanolone (5β-Androsterone) is the excreted metabolite of testosterone and has anticonvulsant activity[1]. Etiocholanolone is a less potent?neurosteroid positive allosteric modulator?(PAM) of the GABAA?receptor than its?enantiomer form[2].

   

4-Androstenediol

(1S,2R,5S,10R,11S,14S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-diol

C19H30O2 (290.2246)


4-Androstenediol is a metabolite of testosterone. Conversely, the conversion of 4-Androstenediol to testosterone has been demonstrated to occur in homogenates of hyperplastic human female adrenal glands. 4-Androstenediol is an anabolic agent that has been found in increased concentration in athletes suspected of doping. 4-Androstenediol has also been found in aqueous and solid nutritional supplements that are commercially available. Studies showing that non-hormonal supplements such as vitamins, minerals and amino acids can contain anabolic androgenic steroids not declared on the labels of the products have been published. These undeclared substances (often prohormones of testosterone) can cause health risks to consumers and might lead to positive results in sports doping control. It has been demonstrated that 4-Androstenediol taken by month is capable of producing in vivo increases in testosterone concentration in apparently healthy young men an women. (PMID: 15808000, 15103700, 10638382, 15370836) [HMDB] 4-Androstenediol is a metabolite of testosterone. Conversely, the conversion of 4-androstenediol to testosterone has been demonstrated to occur in homogenates of hyperplastic human female adrenal glands. 4-Androstenediol is an anabolic agent that has been found in increased concentration in athletes suspected of doping. 4-Androstenediol has also been found in aqueous and solid nutritional supplements that are commercially available. Studies showing that non-hormonal supplements such as vitamins, minerals, and amino acids can contain anabolic androgenic steroids not declared on the labels of the products have been published. These undeclared substances (often prohormones of testosterone) can cause health risks to consumers and might lead to positive results in sports doping control. It has been demonstrated that 4-androstenediol taken by mouth is capable of producing in vivo increases in testosterone concentration in apparently healthy young men an women (PMID: 15808000, 15103700, 10638382, 15370836).

   

5b-Dihydrotestosterone

(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one

C19H30O2 (290.2246)


5beta-Dihydrotestosterone is an intermediate in Androgen and estrogen metabolism. 5beta-Dihydrotestosterone is generated from Testosterone via the enzyme 3-oxo-5beta-steroid 4-dehydrogenase (EC 1.3.99.6). [HMDB] 5beta-Dihydrotestosterone is an intermediate in Androgen and estrogen metabolism. 5beta-Dihydrotestosterone is generated from Testosterone via the enzyme 3-oxo-5beta-steroid 4-dehydrogenase (EC 1.3.99.6).

   

succinylcholine

succinylcholine

[C14H30N2O4]2+ (290.2205)


KEIO_ID S103

   

5-Androstene-3beta,16beta-diol

androst-5-ene-3β,16α-diol

C19H30O2 (290.2246)


   

Succinylcholine

trimethyl[2-({4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl}oxy)ethyl]azanium

C14H30N2O4 (290.2205)


A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]

   

Epietiocholanolone

(1S,2S,5S,7R,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H30O2 (290.2246)


Epietiocholanolone is an anabolic steroid similar in structure to androstenedione. Used by body-builders to add muscle mass, but with unknown side effects. An anabolic steroid similar in structure to androstenedione. It is used by body-builders to add muscle mass, but with unknown side effects. [HMDB]

   

4-Methylphenyl dodecanoate

Dodecanoic acid, 4-methylphenyl ester

C19H30O2 (290.2246)


4-Methylphenyl dodecanoate is a flavouring ingredient with a mild, floral, sweet odour and taste. Flavouring ingredient with a mild, floral, sweet odour and taste

   

5beta-Dihydroepitestosterone

(1S,2S,10R,11S,14R,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one

C19H30O2 (290.2246)


5beta-dihydroepitestosterone is also known as (5beta)-17alpha-Hydroxyandrostan-3-one. 5beta-dihydroepitestosterone is considered to be practically insoluble (in water) and basic

   

(17beta)-17-Hydroxyandrostan-3-one

14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-one

C19H30O2 (290.2246)


   

Androst-5-ene-3beta,17beta-diol

2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-ene-5,14-diol

C19H30O2 (290.2246)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents

   

3-alpha-hydroxy-5-beta-androstan-17-one

5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H30O2 (290.2246)


   

4-Androstene-3,17-diol

2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-ene-5,14-diol

C19H30O2 (290.2246)


   

Androstendiol

2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-13-ene-5,14-diol

C19H30O2 (290.2246)


   

(8R,9R,10R,13S,14S)-10,13-Dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17-diol

(8R,9R,10R,13S,14S)-10,13-Dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17-diol

C19H30O2 (290.2246)


   

(5α)-Androst-1-ene-3,17-diol

5alpha-Androst-1-ene-3beta,17beta-diol

C19H30O2 (290.2246)


   

19-Noranticopalic acid

19-Noranticopalic acid

C19H30O2 (290.2246)


   

(Z)-5-(trideca-4-enyl)resorcinol

(Z)-5-(trideca-4-enyl)resorcinol

C19H30O2 (290.2246)


   

Litsealactone A

(-)-Litsealactone A

C19H30O2 (290.2246)


   
   

Androst-1-ene-3,17-diol

Androst-1-ene-3,17-diol

C19H30O2 (290.2246)


   

Mirceo-commun-saeure

Mirceo-commun-saeure

C19H30O2 (290.2246)


   

5-tridec-8-enylbenzene-1,3-diol

5-tridec-8-enylbenzene-1,3-diol

C19H30O2 (290.2246)


   

Me ester-7,9-Octadecadiynoic acid

Me ester-7,9-Octadecadiynoic acid

C19H30O2 (290.2246)


   

16-oxo-17-nor-(-)-19-Kauranol|16-Oxo-17-nor-(-)-kauran-19-ol|16-Oxo-17-nor-(-)-kauranol-(18)|19-hydroxy-ent-17-norkauran-16-one

16-oxo-17-nor-(-)-19-Kauranol|16-Oxo-17-nor-(-)-kauran-19-ol|16-Oxo-17-nor-(-)-kauranol-(18)|19-hydroxy-ent-17-norkauran-16-one

C19H30O2 (290.2246)


   

ent-8alpha-hydroxylabda-13(16),14-dien-19-al

ent-8alpha-hydroxylabda-13(16),14-dien-19-al

C19H30O2 (290.2246)


   

Dehydrocrepenynsaeure-methylester (14C-markiert)|methyl (14Z)-dehydrocrepenynate|Octadeca-9cis.14cis-dien-12-in-saeuremethylester, 14,15-Dehydro-crepeninsaeuremethylester

Dehydrocrepenynsaeure-methylester (14C-markiert)|methyl (14Z)-dehydrocrepenynate|Octadeca-9cis.14cis-dien-12-in-saeuremethylester, 14,15-Dehydro-crepeninsaeuremethylester

C19H30O2 (290.2246)


   

cis-Parinaric acid methyl ester

9Z,11E,13E,15Z-octadecatraenoic acid, methyl ester

C19H30O2 (290.2246)


   

9,12-octadecadien-6-ynoic acid methyl ester

9,12-octadecadien-6-ynoic acid methyl ester

C19H30O2 (290.2246)


   

6beta,10beta-epoxy-5beta-hydroxyfusicocc-2-ene

6beta,10beta-epoxy-5beta-hydroxyfusicocc-2-ene

C19H30O2 (290.2246)


   

(E)-14-hydroxy-15-norlabda-8(17),12-dien-16-al

(E)-14-hydroxy-15-norlabda-8(17),12-dien-16-al

C19H30O2 (290.2246)


   
   

3-deacetoxynegundoin C|CPB5212-1492-1

3-deacetoxynegundoin C|CPB5212-1492-1

C19H30O2 (290.2246)


   

3beta-hydroxy-15-nor-14-oxo-8(17),12-labdadien-14-al

3beta-hydroxy-15-nor-14-oxo-8(17),12-labdadien-14-al

C19H30O2 (290.2246)


   

14-methoxy-15,16-dinor-5alphaH,9alphaH-labda-13(E),8(17)-dien-12-one

14-methoxy-15,16-dinor-5alphaH,9alphaH-labda-13(E),8(17)-dien-12-one

C19H30O2 (290.2246)


   

11alpha-Hydroxy-5alpha-androstan-3-on

11alpha-Hydroxy-5alpha-androstan-3-on

C19H30O2 (290.2246)


   

15-nor-14-oxo-8(17),12-labdadien-18-ol

15-nor-14-oxo-8(17),12-labdadien-18-ol

C19H30O2 (290.2246)


   

Sterculynic acid

7-(2-non-8-yn-1-ylcycloprop-1-en-1-yl)heptanoic acid

C19H30O2 (290.2246)


A long-chain, polyunsaturated fatty acid composed of 9-octadecenoic acid having a terminal alkyne group and a 9,10-cyclopropenyl group.

   
   

fusicoauritone

fusicoauritone

C19H30O2 (290.2246)


   

13-phenyltridecanoic Acid

13-phenyltridecanoic Acid

C19H30O2 (290.2246)


   

Me ester-(3E,9Z,12Z,15Z)-3,9,12,15-Octadecatetraenoic acid

Me ester-(3E,9Z,12Z,15Z)-3,9,12,15-Octadecatetraenoic acid

C19H30O2 (290.2246)


   

Stearidonic Acid methyl ester

6Z,9Z,12Z,15Z-octadecatetraenoic acid, methyl ester

C19H30O2 (290.2246)


   

5-beta-Androstan-17-beta-ol-3-one

(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one

C19H30O2 (290.2246)


Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

Epiandrosterone

Epiandrosterone

C19H30O2 (290.2246)


A 3beta-hydroxy steroid that is (5alpha)-androstane substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones relative retention time with respect to 9-anthracene Carboxylic Acid is 1.312 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong. Epiandrosterone is a steroid hormone with weak androgenic activity. Epiandrosterone is naturally produced by the enzyme 5α-reductase from the adrenal hormone DHEA.

   

Stanolone

17beta-hydroxy-androstan-3-one

C19H30O2 (290.2246)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03B - Androgens > G03BB - 5-androstanon (3) derivatives A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2805 Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

Androsterone

Androsterone

C19H30O2 (290.2246)


An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone . C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

MLS000563094-01!(3S,5R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one

"MLS000563094-01!(3S,5R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one"

C19H30O2 (290.2246)


   

MLS001304190-01!

MLS001304190-01!

C19H30O2 (290.2246)


   

MLS002153962-01!3-alpha-Hydroxy-5-beta-androstan-17-one53-42-9

MLS002153962-01!3-alpha-Hydroxy-5-beta-androstan-17-one53-42-9

C19H30O2 (290.2246)


   

Etiocholanolone

3alpha-hydroxy-5beta-androstan-17-one

C19H30O2 (290.2246)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C308 - Immunotherapeutic Agent > C2139 - Immunostimulant COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Etiocholanolone (5β-Androsterone) is the excreted metabolite of testosterone and has anticonvulsant activity[1]. Etiocholanolone is a less potent?neurosteroid positive allosteric modulator?(PAM) of the GABAA?receptor than its?enantiomer form[2]. Etiocholanolone (5β-Androsterone) is the excreted metabolite of testosterone and has anticonvulsant activity[1]. Etiocholanolone is a less potent?neurosteroid positive allosteric modulator?(PAM) of the GABAA?receptor than its?enantiomer form[2]. Etiocholanolone (5β-Androsterone) is the excreted metabolite of testosterone and has anticonvulsant activity[1]. Etiocholanolone is a less potent?neurosteroid positive allosteric modulator?(PAM) of the GABAA?receptor than its?enantiomer form[2].

   

Epietiocholanolone

Androstan-17-one,3-hydroxy-, (3b,5b)-

C19H30O2 (290.2246)


A 3beta-hydroxy steroid that is 5beta-androstane substituted by a hydroxy group at position 3beta and an oxo group at position 17. It is a metabolite of testosterone.

   

Androst-5-ene-3,17-diol

Androst-5-ene-3,17-diol

C19H30O2 (290.2246)


Origin: Animal; SubCategory_DNP: The sterols, Androstanes

   

Androsterone_major

Androsterone_major

C19H30O2 (290.2246)


   

Epiandrosterone_major

Epiandrosterone_major

C19H30O2 (290.2246)


   

Androsterone_31.8\\%

Androsterone_31.8\\%

C19H30O2 (290.2246)


   

Epiandrosterone_96.1\\%

Epiandrosterone_96.1\\%

C19H30O2 (290.2246)


   

h_2_Etiocholanolone

h_2_Etiocholanolone

C19H30O2 (290.2246)


   

h_282_4_androstene_3a_17b_diol

h_282_4_androstene_3a_17b_diol

C19H30O2 (290.2246)


   

h_127_1_androstenediol

h_127_1_androstenediol

C19H30O2 (290.2246)


   

Isoandrosterone

(3S,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one

C19H30O2 (290.2246)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Epiandrosterone is a steroid hormone with weak androgenic activity. Epiandrosterone is naturally produced by the enzyme 5α-reductase from the adrenal hormone DHEA.

   

7R,9,14R-trimethyl-2E,4E,8E,10E-hexadecatetraenoic acid

7R,9,14R-trimethyl-2E,4E,8E,10E-hexadecatetraenoic acid

C19H30O2 (290.2246)


   

10,13-nonadecadiynoic acid

10,13-nonadecadiynoic acid

C19H30O2 (290.2246)


   

P-Tolyl laurate

Dodecanoic acid, 4-methylphenyl ester

C19H30O2 (290.2246)


   

FA 19:4

7R,9,14R-trimethyl-2E,4E,8E,10E-hexadecatetraenoic acid

C19H30O2 (290.2246)


   

Androstenediol

Androst-5-ene-3beta,17beta-diol

C19H30O2 (290.2246)


A 3beta-hydroxy-Delta(5)-steroid that is 3beta-hydroxyandrost-5-ene carrying an additional hydroxy group at position 17beta. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

ST 19:1;O2

(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one

C19H30O2 (290.2246)


   

5-((Z)-tridec-8-en-1-yl)resorcinol

(Z)-5-(tridec-8-en-1-yl)benzene-1,3-diol

C19H30O2 (290.2246)


   

Dodecyltrimethoxysilane

Dodecyltrimethoxysilane

C15H34O3Si (290.2277)


   

Benzoic acid, dodecylester

Benzoic acid, dodecylester

C19H30O2 (290.2246)


   

beta-santalyl butyrate

beta-santalyl butyrate

C19H30O2 (290.2246)


   

santalyl butyrate

santalyl butyrate

C19H30O2 (290.2246)


   

1,4-bis(di-i-propylphosphino)butane

1,4-bis(di-i-propylphosphino)butane

C16H36P2 (290.2292)


   

(4-tert-butyl-benzyl)-(3-morpholin-4-yl-propyl)-amine

(4-tert-butyl-benzyl)-(3-morpholin-4-yl-propyl)-amine

C18H30N2O (290.2358)


   

diisooctylphosphinic acid

diisooctylphosphinic acid

C16H35O2P (290.2375)


   

Dodecyl benzoate

Dodecyl benzoate

C19H30O2 (290.2246)


   

Benzyl Laurate

Benzyl Laurate

C19H30O2 (290.2246)


   

n-Octyl Sulfone

n-Octyl Sulfone

C16H34O2S (290.2279)


   

6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide

6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide

C18H30N2O (290.2358)


   

2,4-Nonadecadiynoic acid

2,4-Nonadecadiynoic acid

C19H30O2 (290.2246)


   

4-n-dodecyloxybenzaldehyde

4-n-dodecyloxybenzaldehyde

C19H30O2 (290.2246)


   

2-(2-Dodecylsulfanylethoxy)ethanol

2-(2-Dodecylsulfanylethoxy)ethanol

C16H34O2S (290.2279)


   

(17beta)-17-Hydroxyandrostan-3-one

(17beta)-17-Hydroxyandrostan-3-one

C19H30O2 (290.2246)


   

3-(3,5-Ditert-butyl-4-hydroxyphenyl)-2,2-dimethylpropanal

3-(3,5-Ditert-butyl-4-hydroxyphenyl)-2,2-dimethylpropanal

C19H30O2 (290.2246)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists

   

Nicotinamide, N,N-dihexyl-

Nicotinamide, N,N-dihexyl-

C18H30N2O (290.2358)


   

(2alpha,5alpha,17beta)-17-Hydroxy-2-methylestran-3-one

(2alpha,5alpha,17beta)-17-Hydroxy-2-methylestran-3-one

C19H30O2 (290.2246)


   

Methyl stearidonate

Methyl stearidonate

C19H30O2 (290.2246)


   

A-diol

A-Androst-1-ene-3

C19H30O2 (290.2246)


   

5alpha-Androst-2-ene-1alpha,17beta-diol

5alpha-Androst-2-ene-1alpha,17beta-diol

C19H30O2 (290.2246)


   

1-Androstenediol

(5α)-Androst-1-ene-3,17-diol

C19H30O2 (290.2246)


   

3-alpha-hydroxy-5-beta-androstan-17-one

5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one

C19H30O2 (290.2246)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

(8R,9R,10R,13S,14S)-10,13-Dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17-diol

(8R,9R,10R,13S,14S)-10,13-Dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17-diol

C19H30O2 (290.2246)


   

4-Androstene-3,17-diol

2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-ene-5,14-diol

C19H30O2 (290.2246)


   

Vitex norditerpenoid 1

Vitex norditerpenoid 1

C19H30O2 (290.2246)


A natural product found in Vitex trifolia.

   

(10R,13S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

(10R,13S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

C19H30O2 (290.2246)


   

10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol

C19H30O2 (290.2246)


   

4-Androstene-3alpha,17beta-diol

4-Androstene-3alpha,17beta-diol

C19H30O2 (290.2246)


   

(3R,5R,8R,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one

(3R,5R,8R,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one

C19H30O2 (290.2246)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Androstan-17-one, 3-hydroxy-, (3alpha,5alpha)-

Androstan-17-one, 3-hydroxy-, (3alpha,5alpha)-

C19H30O2 (290.2246)


   

Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-

Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-

C19H30O2 (290.2246)


   

Androstan-17-one, 3-hydroxy-, (3beta,5alpha)-

Androstan-17-one, 3-hydroxy-, (3beta,5alpha)-

C19H30O2 (290.2246)


   

(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoic acid

(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoic acid

C19H30O2 (290.2246)


   

3,7,11-Trimethylcyclotetradeca-2(E),6(E),10(E)-trienyl acetate

3,7,11-Trimethylcyclotetradeca-2(E),6(E),10(E)-trienyl acetate

C19H30O2 (290.2246)


   

Hexanal benzyl cis-3-hexenyl acetal

Hexanal benzyl cis-3-hexenyl acetal

C19H30O2 (290.2246)


   

Hexanal benzyl[(E)-2-hexenyl]acetal

Hexanal benzyl[(E)-2-hexenyl]acetal

C19H30O2 (290.2246)


   

Ethyl=(2E,4E,8E)-5,9,13-trimethyl-2,4,8,12-tetradecatetraenoate

Ethyl=(2E,4E,8E)-5,9,13-trimethyl-2,4,8,12-tetradecatetraenoate

C19H30O2 (290.2246)


   

Ethyl 5,9,13-trimethyl-(2E,4E,8Z,12E)-2,4,8,12-tetradecatetraenoate

Ethyl 5,9,13-trimethyl-(2E,4E,8Z,12E)-2,4,8,12-tetradecatetraenoate

C19H30O2 (290.2246)


   

(2XI,4AS,5S,8AS)-(-)-2,5beta-Dimethyl-8abeta-formyl-5alpha-(4-methyl-3-pentenyl)-3,4,4A,5,6,7,8,8A-octahydronaphthalen-1(2H)-one

(2XI,4AS,5S,8AS)-(-)-2,5beta-Dimethyl-8abeta-formyl-5alpha-(4-methyl-3-pentenyl)-3,4,4A,5,6,7,8,8A-octahydronaphthalen-1(2H)-one

C19H30O2 (290.2246)


   

[2xi,4aS,(+)]-5beta,8abeta-Dimethyl-2-formyl-5-(4-methyl-3-pentenyl)-3,4,4aalpha,5,6,7,8,8a-octahydronaphthalene-1(2H)-one

[2xi,4aS,(+)]-5beta,8abeta-Dimethyl-2-formyl-5-(4-methyl-3-pentenyl)-3,4,4aalpha,5,6,7,8,8a-octahydronaphthalene-1(2H)-one

C19H30O2 (290.2246)


   

2alpha-Allyl-2beta-formyl-11alpha-methoxy-6,6,8beta-trimethyl-5alpha-tricyclo(6.3.0.0(1,5))undecane

2alpha-Allyl-2beta-formyl-11alpha-methoxy-6,6,8beta-trimethyl-5alpha-tricyclo(6.3.0.0(1,5))undecane

C19H30O2 (290.2246)


   

11-(Allyloxymethyliden)-2alpha-methoxy-5beta,7,7-trimethyl-8alpha-tricyclo(6.3.0.0(1,5))undecane

11-(Allyloxymethyliden)-2alpha-methoxy-5beta,7,7-trimethyl-8alpha-tricyclo(6.3.0.0(1,5))undecane

C19H30O2 (290.2246)


   

[(2E,6Z,10E)-3,7,11-trimethylcyclotetradeca-2,6,10-trien-1-yl] acetate

[(2E,6Z,10E)-3,7,11-trimethylcyclotetradeca-2,6,10-trien-1-yl] acetate

C19H30O2 (290.2246)


   

5beta-Dihydrotestosterone

(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one

C19H30O2 (290.2246)


A 17beta-hydroxyandrostan-3-one that has beta- configuration at position 5. It is a metabolite of testosterone.

   

5beta-Dihydroepitestosterone

5beta-Dihydroepitestosterone

C19H30O2 (290.2246)


An androstanoid with a 5beta-configuration formed by reduction across the C4-C5 double bond of epitestosterone.

   

16:4(2E,4E,8E,10E)(7Me[R],9Me,14Me[R])

16:4(2E,4E,8E,10E)(7Me[R],9Me,14Me[R])

C19H30O2 (290.2246)


   

17beta-Hydroxy-5alpha-androstan-3-one

17beta-Hydroxy-5alpha-androstan-3-one

C19H30O2 (290.2246)


A 17beta-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with alpha-configuration at position 5.

   

3alpha-hydroxy-5beta-androstan-17-one

3alpha-hydroxy-5beta-androstan-17-one

C19H30O2 (290.2246)


An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.

   

WE(19:4)

WE(2:0_17:4)

C19H30O2 (290.2246)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

1-Hydroxy-3-oxo-steroid

1-Hydroxy-3-oxo-steroid

C19H30O2 (290.2246)


   

Nonadecatetraenoic acid

Nonadecatetraenoic acid

C19H30O2 (290.2246)


   

methyl octadeca-9,12-dien-6-ynoate

methyl octadeca-9,12-dien-6-ynoate

C19H30O2 (290.2246)


   

methyl (11e,13e)-octadeca-9,11,13,15-tetraenoate

methyl (11e,13e)-octadeca-9,11,13,15-tetraenoate

C19H30O2 (290.2246)


   

6,9a,11a-trimethyl-1h,2h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-b]furan-6-ol

6,9a,11a-trimethyl-1h,2h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-b]furan-6-ol

C19H30O2 (290.2246)


   

(2e)-4-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-(hydroxymethyl)but-2-enal

(2e)-4-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-(hydroxymethyl)but-2-enal

C19H30O2 (290.2246)


   

(2r,3e,5e)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)octa-3,5-dienoic acid

(2r,3e,5e)-2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)octa-3,5-dienoic acid

C19H30O2 (290.2246)


   

10-isopropyl-4,7,13-trimethyl-14-oxatetracyclo[9.2.1.0¹,⁵.0⁷,¹¹]tetradec-4-en-2-ol

10-isopropyl-4,7,13-trimethyl-14-oxatetracyclo[9.2.1.0¹,⁵.0⁷,¹¹]tetradec-4-en-2-ol

C19H30O2 (290.2246)


   

(1s,2r,7r,10r,11s,13r)-10-isopropyl-4,7,13-trimethyl-14-oxatetracyclo[9.2.1.0¹,⁵.0⁷,¹¹]tetradec-4-en-2-ol

(1s,2r,7r,10r,11s,13r)-10-isopropyl-4,7,13-trimethyl-14-oxatetracyclo[9.2.1.0¹,⁵.0⁷,¹¹]tetradec-4-en-2-ol

C19H30O2 (290.2246)


   

methyl 2-phenyldodecanoate

methyl 2-phenyldodecanoate

C19H30O2 (290.2246)


   

(2z,6r)-2-methyl-6-(4-methylcyclohexa-1,3-dien-1-yl)hept-2-en-1-yl 2-methylpropanoate

(2z,6r)-2-methyl-6-(4-methylcyclohexa-1,3-dien-1-yl)hept-2-en-1-yl 2-methylpropanoate

C19H30O2 (290.2246)


   

5-[1-(2,2-dimethylcyclopentylidene)ethyl]-4,4-dimethyl-hexahydro-2-benzofuran-1-one

5-[1-(2,2-dimethylcyclopentylidene)ethyl]-4,4-dimethyl-hexahydro-2-benzofuran-1-one

C19H30O2 (290.2246)


   

5α-androstene-3β,17β-diol

5α-androstene-3β,17β-diol

C19H30O2 (290.2246)


   

5-[(4z)-tridec-4-en-1-yl]benzene-1,3-diol

5-[(4z)-tridec-4-en-1-yl]benzene-1,3-diol

C19H30O2 (290.2246)


   

(5e,7e,9e,11e)-tetradeca-5,7,9,11-tetraen-1-yl 3-methylbutanoate

(5e,7e,9e,11e)-tetradeca-5,7,9,11-tetraen-1-yl 3-methylbutanoate

C19H30O2 (290.2246)


   

methyl 12-phenyldodecanoate

methyl 12-phenyldodecanoate

C19H30O2 (290.2246)


   

(3r,4ar,6ar,9as,9br)-3-ethenyl-3,4a,7,7,9a-pentamethyl-hexahydro-1h-indeno[5,4-b]pyran-8-one

(3r,4ar,6ar,9as,9br)-3-ethenyl-3,4a,7,7,9a-pentamethyl-hexahydro-1h-indeno[5,4-b]pyran-8-one

C19H30O2 (290.2246)


   

(3as,5ar,6r,9ar,9br,11ar)-6,9a,11a-trimethyl-1h,2h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-b]furan-6-ol

(3as,5ar,6r,9ar,9br,11ar)-6,9a,11a-trimethyl-1h,2h,3ah,5h,5ah,7h,8h,9h,9bh,10h,11h-phenanthro[1,2-b]furan-6-ol

C19H30O2 (290.2246)


   

(1s,3as,3bs,5as,7r,9ar,9bs,11as)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol

(1s,3as,3bs,5as,7r,9ar,9bs,11as)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol

C19H30O2 (290.2246)


   

4-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-2-(hydroxymethyl)but-2-enal

4-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-2-(hydroxymethyl)but-2-enal

C19H30O2 (290.2246)


   

2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)octa-3,5-dienoic acid

2,6-dimethyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)octa-3,5-dienoic acid

C19H30O2 (290.2246)


   

2-[(2r,4ar,8ar)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl]prop-2-en-1-yl 2-methylpropanoate

2-[(2r,4ar,8ar)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl]prop-2-en-1-yl 2-methylpropanoate

C19H30O2 (290.2246)


   

methyl (9z,12z)-octadeca-9,12-dien-6-ynoate

methyl (9z,12z)-octadeca-9,12-dien-6-ynoate

C19H30O2 (290.2246)


   

methyl (9z,11e,13e,15z)-octadeca-9,11,13,15-tetraenoate

methyl (9z,11e,13e,15z)-octadeca-9,11,13,15-tetraenoate

C19H30O2 (290.2246)


   

methyl octadeca-9,14-dien-12-ynoate

methyl octadeca-9,14-dien-12-ynoate

C19H30O2 (290.2246)


   

7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-1h-2-benzofuran-1-ol

7-ethylidene-6-(1,3,3-trimethylcyclohexyl)-3,3a,4,7a-tetrahydro-1h-2-benzofuran-1-ol

C19H30O2 (290.2246)


   

(2e)-4-[(1s,4ar,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-methylbut-2-enal

(2e)-4-[(1s,4ar,5r,8ar)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-methylbut-2-enal

C19H30O2 (290.2246)


   

1-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-4-methoxybut-3-en-2-one

1-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-4-methoxybut-3-en-2-one

C19H30O2 (290.2246)


   

2-methyl-6-(4-methylcyclohexa-1,3-dien-1-yl)hept-2-en-1-yl 2-methylpropanoate

2-methyl-6-(4-methylcyclohexa-1,3-dien-1-yl)hept-2-en-1-yl 2-methylpropanoate

C19H30O2 (290.2246)


   

(3e)-1-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-4-methoxybut-3-en-2-one

(3e)-1-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-4-methoxybut-3-en-2-one

C19H30O2 (290.2246)


   

methyl (9z,14z)-octadeca-9,14-dien-12-ynoate

methyl (9z,14z)-octadeca-9,14-dien-12-ynoate

C19H30O2 (290.2246)


   

9a-hydroxy-7-isopropyl-3,4a,9-trimethyl-1h,4h,5h,6h,7h,7ah,8h,9h-cyclopenta[f]azulen-2-one

9a-hydroxy-7-isopropyl-3,4a,9-trimethyl-1h,4h,5h,6h,7h,7ah,8h,9h-cyclopenta[f]azulen-2-one

C19H30O2 (290.2246)


   

9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol

9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,9bh,10h,11h-cyclopenta[a]phenanthrene-1,7-diol

C19H30O2 (290.2246)


   

5-{1-[(1e)-2,2-dimethylcyclopentylidene]ethyl}-4,4-dimethyl-hexahydro-2-benzofuran-1-one

5-{1-[(1e)-2,2-dimethylcyclopentylidene]ethyl}-4,4-dimethyl-hexahydro-2-benzofuran-1-one

C19H30O2 (290.2246)


   

1-(2-hydroxy-6-undecylphenyl)ethanone

1-(2-hydroxy-6-undecylphenyl)ethanone

C19H30O2 (290.2246)


   

(1s,3ar,7z,7ar)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,7a-tetrahydro-1h-2-benzofuran-1-ol

(1s,3ar,7z,7ar)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,7a-tetrahydro-1h-2-benzofuran-1-ol

C19H30O2 (290.2246)


   

(2e)-5-[(1s,4ar,5r,8as)-5,8a-dimethyl-2-methylidene-octahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

(2e)-5-[(1s,4ar,5r,8as)-5,8a-dimethyl-2-methylidene-octahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C19H30O2 (290.2246)


   

tetradeca-5,7,9,11-tetraen-1-yl 3-methylbutanoate

tetradeca-5,7,9,11-tetraen-1-yl 3-methylbutanoate

C19H30O2 (290.2246)


   

4-[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-methylbut-2-enal

4-[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-methylbut-2-enal

C19H30O2 (290.2246)


   

3-methyl-5-(1,2,5-trimethyl-3,7,8,8a-tetrahydro-2h-naphthalen-1-yl)pentanoic acid

3-methyl-5-(1,2,5-trimethyl-3,7,8,8a-tetrahydro-2h-naphthalen-1-yl)pentanoic acid

C19H30O2 (290.2246)


   

(3ar,5s,7ar)-5-{1-[(1z)-2,2-dimethylcyclopentylidene]ethyl}-4,4-dimethyl-hexahydro-2-benzofuran-1-one

(3ar,5s,7ar)-5-{1-[(1z)-2,2-dimethylcyclopentylidene]ethyl}-4,4-dimethyl-hexahydro-2-benzofuran-1-one

C19H30O2 (290.2246)


   

(4ar,7r,7as,9s,9as)-9a-hydroxy-7-isopropyl-3,4a,9-trimethyl-1h,4h,5h,6h,7h,7ah,8h,9h-cyclopenta[f]azulen-2-one

(4ar,7r,7as,9s,9as)-9a-hydroxy-7-isopropyl-3,4a,9-trimethyl-1h,4h,5h,6h,7h,7ah,8h,9h-cyclopenta[f]azulen-2-one

C19H30O2 (290.2246)


   

2-(4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl)prop-2-en-1-yl 2-methylpropanoate

2-(4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl)prop-2-en-1-yl 2-methylpropanoate

C19H30O2 (290.2246)


   

(3r)-5-[(1s,2r,8ar)-1,2,5-trimethyl-3,7,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoic acid

(3r)-5-[(1s,2r,8ar)-1,2,5-trimethyl-3,7,8,8a-tetrahydro-2h-naphthalen-1-yl]-3-methylpentanoic acid

C19H30O2 (290.2246)


   

(5r)-5-methyl-3-[(1e,11e)-tetradeca-1,11-dien-1-yl]-5h-furan-2-one

(5r)-5-methyl-3-[(1e,11e)-tetradeca-1,11-dien-1-yl]-5h-furan-2-one

C19H30O2 (290.2246)


   

2-{2,5,5,8a-tetramethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxolan]-5'-ylidene}acetaldehyde

2-{2,5,5,8a-tetramethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxolan]-5'-ylidene}acetaldehyde

C19H30O2 (290.2246)


   

(2e)-4-[(1s,4ar,6s,8ar)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-methylbut-2-enal

(2e)-4-[(1s,4ar,6s,8ar)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-methylbut-2-enal

C19H30O2 (290.2246)